NExT Review Process

All NExT Program applications will be evaluated by a Special Emphasis Panel (SEP) consisting of non-NCI experts in cancer drug discovery and development. The applications will undergo further scientific review by NExT Discovery or Development Committees composed of NCI staff with expertise in translational research and drug discovery and development. The NExT Committees' review will finalize the list of Top Tier applications from each cycle.